Search Results - Matteo Carlino

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    177 Exploring the relationship between tumour heterogeneity and response to immunotherapy in malignant pleural mesothelioma

    177 Exploring the relationship between tumour heterogeneity and response to immunotherapy in malignant pleural mesothelioma by Golo Ahlenstiel, Matteo Carlino, Bo Gao, Adnan Nagrial, Hema Mahajan, Fabio Luciani, Dmitrii Shek, Scott Read

    Published 2023-11-01
    Article
    Save to List
    Saved in:
  2. 2
    Five‐year survival and clinical correlates among patients with advanced non‐small cell lung cancer, melanoma and renal cell carcinoma treated with immune check‐point inhibitors in Australian tertiary oncology centres

    Five‐year survival and clinical correlates among patients with advanced non‐small cell lung cancer, melanoma and renal cell carcinoma treated with immune check‐point inhibitors in... by Lauren J Brown, Ines Pires da Silva, Tania Moujaber, Bo Gao, Rina Hui, Howard Gurney, Matteo Carlino, Adnan Nagrial

    Published 2023-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab

    Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab by Richard A Scolyer, Matteo Carlino, Kazi J Nahar, Robert V Rawson, Tasnia Ahmed, Stephen Tattersall, Neomal Sandanayake, Christopher J Kiely, Umaimainthan Palendira

    Published 2020-07-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial

    Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial by Linda Mileshkin, Ben Markman, Oliver Klein, Damien Kee, Jonathan Cebon, Andreas Behren, Matteo Carlino, Bo Gao, Jessica da Gama Duarte, Luke Quigley, Louise Jackett, Richelle Linklater, Andrew Strickland, Clare Scott, Jodie Palmer

    Published 2021-11-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    194 A multicenter characterization of chronic toxicities following adjuvant anti-PD-1 therapy for high risk resected melanoma

    194 A multicenter characterization of chronic toxicities following adjuvant anti-PD-1 therapy for high risk resected melanoma by Andrew Haydon, Rebecca Johnson, Iman Osman, Janice Mehnert, Suthee Rapisuwon, Douglas Johnson, Ryan Sullivan, Matteo Carlino, Alexander Menzies, Prachi Bhave, James Patrinely, Aleigha Lawless, Amelia Sawyers, Maya Dimitrova, Hui Yeohc, Marisa Palmeri, Elizabeth Davis, Georgina Long

    Published 2020-11-01
    Article
    Save to List
    Saved in:
  6. 6
    Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma

    Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma by Lisa Zimmer, Serigne Lo, Celeste Lebbe, Olivier Michielin, Ines Pires da Silva, Paolo Antonio Ascierto, Matteo Carlino, Alexander Menzies, Douglas B Johnson, Claudia Trojanello, Georgina Long, Tasnia Ahmed, Clara Allayous, Johanna Mangana, Florentia Dimitriou, Danny Zakria, Camille Gerard

    Published 2022-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: